Calendario de promoción Intensity Therapeutics, Inc.
Horario avanzado
gráfico sencillo
Acerca de la empresa Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. Its lead product candidate includes INT230-6, a clinical trial for the treatment of refractory solid tumors and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. The company was incorporated in 2012 and is headquartered in Westport, Connecticut.| IPO date | 2023-06-30 |
|---|---|
| ISIN | US45828J1034 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://intensitytherapeutics.com |
| Цена ао | 5.33 |
| Cambio de precio por día: | +3.68% (1.9) |
|---|---|
| Cambio de precio por semana.: | +4.79% (1.88) |
| Cambio de precio por mes: | -29.33% (2.7875) |
| Cambio de precio en 3 meses.: | -48.56% (3.83) |
| Cambio de precio en seis meses: | -59.55% (4.87) |
| Cambio de precio por año: | -77.01% (8.57) |
| Cambio de precio en 3 años.: | 0% (1.97) |
| Cambio de precio en 5 años.: | 0% (1.97) |
| Cambio de precio en 10 años.: | 0% (1.97) |
| Cambio de precio desde principios de año.: | -35.41% (3.05) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Instituciones | Volumen | Compartir, % |
|---|---|---|
| HOHIMER WEALTH MANAGEMENT, LLC | 186464 | 1.36 |
| Sigma Planning Corp | 48144 | 0.35 |
| Millennium Management LLC | 24822 | 0.18 |
| Geode Capital Management, LLC | 23070 | 0.17 |
| Blackrock Inc. | 10239 | 0.07 |
| Wells Fargo & Company | 2480 | 0.02 |
| Osaic Holdings Inc | 2000 | 0.01 |
| Tower Research Capital LLC (TRC) | 1027 | 0.01 |
| Glassman Wealth Services | 200 | 0 |
| JP Morgan Chase & Company | 1 | 0 |
| ETF | Compartir, % | Rentabilidad del año, % | Dividendos, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.00866 | 17.09 | 1.54048 |
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Mr. Lewis H. Bender M.A., M.B.A., M.S. | Founder, President, CEO & Chairman of the Board | 1.1M | 1959 (66 años) |
| Mr. John Wesolowski CPA, M.B.A. | Principal Accounting Officer & Controller | 272.37k | 1960 (65 años) |
| Mr. James M. Ahlers | Executive Vice President of Corporate Finance | 75.09k | 1964 (61 año) |
| Mr. Brian Schwartz M.D. | Executive Vice President of Clinical Development | N/A | |
| Mr. Joseph Talamo CPA, M.B.A. | Chief Financial Officer | N/A | 1969 (56 años) |
DIRECCIÓN: United States, Westport. CT, 61 Wilton Road - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://intensitytherapeutics.com
Sitio web: https://intensitytherapeutics.com
